Latest News and Press Releases
Want to stay updated on the latest news?
-
Series C round led by Deep Track Capital with participation from additional new and existing investors Financing will fund early-to-mid-stage clinical studies for ATTO-1310 in chronic pruritus and...
-
Orennia Inc. today announced the closing of its Series C growth financing, led by Decarbonization Partners, a partnership between BlackRock and Temasek.
-
CHF 50 Million extension round co-led by Cormorant Asset Management, with participation from other existing investors Proceeds will be used to support the advancement of multiple first-in-class and...
-
35Pharma Closes Series C Financing to Advance Clinical Pipeline of Activin Inhibitors for Pulmonary Hypertension, Cardiometabolic Disease and Obesity
-
SAN FRANCISCO, Oct. 24, 2024 (GLOBE NEWSWIRE) -- Finix, the full-stack payment processor enabling businesses to accept and send payments online and in-store, today announced it has raised $75...
-
SAN FRANCISCO, Oct. 24, 2024 (GLOBE NEWSWIRE) -- Simbe, a leading provider of Store Intelligence™ solutions, today announced the closing of a $50 million Series C equity financing round led by...
-
Oshi Health Raises $60M Series C to Strengthen Its Position as the Category Leader for Virtual Digestive Care
-
Existing investors and new investor Double Point Ventures join forces to support ImmunOs TherapeuticsInvestment secures funding of ongoing promising clinical trial of IOS-1002 in solid cancers ...
-
WARREN, N.J., Aug. 22, 2024 (GLOBE NEWSWIRE) -- Tevogen Bio Holdings Inc. (“Tevogen” or “Tevogen Bio”) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech pioneer developing...
-
Funds to support Phase Ib clinical trial of HRX-215 in the US and an international multicenter Phase IIa clinical trial in liver regenerationElias Papatheodorou moves from Chair of the Board to CEO of...